{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:19:53Z","timestamp":1771064393810,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011748","name":"Phospholipid Research Center","doi-asserted-by":"publisher","award":["PUH-2021-093\/1-1"],"award-info":[{"award-number":["PUH-2021-093\/1-1"]}],"id":[{"id":"10.13039\/501100011748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.nano.2023.102731","type":"journal-article","created":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T02:47:03Z","timestamp":1703645223000},"page":"102731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Improved pharmacokinetics and enhanced efficacy of the vancomycin derivative FU002 using a liposomal nanocarrier"],"prefix":"10.1016","volume":"56","author":[{"given":"Julia","family":"Werner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Umst\u00e4tter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Hertlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbro","family":"Beijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Kleist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"M\u00fchlberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Haberkorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Knut","family":"Ohlsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gert","family":"Fricker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Mier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Uhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"SEP","key":"10.1016\/j.nano.2023.102731_bb0005","first-page":"1","article-title":"The antimicrobial resistance crisis: causes, consequences, and management","volume":"2","author":"Michael","year":"2014","journal-title":"Front Public Heal"},{"issue":"10325","key":"10.1016\/j.nano.2023.102731_bb0010","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.nano.2023.102731_bb0015","first-page":"110","article-title":"The review on antimicrobial resistance","volume":"7","author":"O\u2019Neill","year":"2016","journal-title":"Arch Pharm Pract"},{"issue":"11","key":"10.1016\/j.nano.2023.102731_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1002184","article-title":"Will 10 million people die a year due to antimicrobial resistance by 2050?","volume":"13","author":"de Kraker","year":"2016","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.nano.2023.102731_bb0025","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","article-title":"Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European economic area in 2015: a population-level modelling analysis","volume":"19","author":"Cassini","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.nano.2023.102731_bb0030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1086\/491709","article-title":"Vancomycin: a history","volume":"42","author":"Levine","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.nano.2023.102731_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics10091116","article-title":"Alternatives to fight vancomycin-resistant staphylococci and enterococci","volume":"10","author":"Ba\u00ebtz","year":"2021","journal-title":"Antibiotics"},{"issue":"suppl 3","key":"10.1016\/j.nano.2023.102731_bb0040","article-title":"Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections","volume":"45","author":"Micek","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.nano.2023.102731_bb0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1139\/cjm-2019-0309","article-title":"Renaissance of vancomycin: approaches for breaking antibiotic resistance in multidrug-resistant bacteria","volume":"66","author":"M\u00fchlberg","year":"2020","journal-title":"Can J Microbiol"},{"issue":"5","key":"10.1016\/j.nano.2023.102731_bb0050","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1021\/acsinfecdis.7b00258","article-title":"Developments in glycopeptide antibiotics","volume":"4","author":"Blaskovich","year":"2018","journal-title":"ACS Infect Dis"},{"issue":"7","key":"10.1016\/j.nano.2023.102731_bb0055","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1021\/acs.jmedchem.8b01093","article-title":"Battle against vancomycin-resistant bacteria: recent developments in chemical strategies","volume":"62","author":"Dhanda","year":"2019","journal-title":"J Med Chem"},{"issue":"18","key":"10.1016\/j.nano.2023.102731_bb0060","doi-asserted-by":"crossref","first-page":"11952","DOI":"10.1021\/acs.chemrev.6b00820","article-title":"Total syntheses of vancomycin-related glycopeptide antibiotics and key analogues","volume":"117","author":"Okano","year":"2017","journal-title":"Chem Rev"},{"issue":"9","key":"10.1016\/j.nano.2023.102731_bb0065","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/ja.2014.111","article-title":"Glycopeptide antibiotics: back to the future","volume":"67","author":"Butler","year":"2014","journal-title":"J Antibiot (Tokyo)"},{"issue":"47","key":"10.1016\/j.nano.2023.102731_bb0070","doi-asserted-by":"crossref","first-page":"16140","DOI":"10.1021\/jacs.8b08711","article-title":"A dual-function antibiotic-transporter conjugate exhibits superior activity in sterilizing MRSA biofilms and killing persister cells","volume":"140","author":"Antonoplis","year":"2018","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.nano.2023.102731_bb0075","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/ph13060110","article-title":"Vancomycin-lipopeptide conjugates with high antimicrobial activity on vancomycin-resistant enterococci","volume":"13","author":"M\u00fchlberg","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.nano.2023.102731_bb0080","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41467-017-02123-w","article-title":"Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria","volume":"9","author":"Blaskovich","year":"2018","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.nano.2023.102731_bb0085","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1021\/jm500270w","article-title":"Membrane active vancomycin analogues: a strategy to combat bacterial resistance","volume":"57","author":"Yarlagadda","year":"2014","journal-title":"J Med Chem"},{"issue":"11","key":"10.1016\/j.nano.2023.102731_bb0090","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1021\/acs.accounts.0c00569","article-title":"Maxamycins: durable antibiotics derived by rational redesign of vancomycin","volume":"53","author":"Wu","year":"2020","journal-title":"Acc Chem Res"},{"issue":"9","key":"10.1016\/j.nano.2023.102731_bb0095","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1021\/acschembio.9b00565","article-title":"Vancomycin-arginine conjugate inhibits growth of carbapenem-resistant E. Coli and targets cell-wall synthesis","volume":"14","author":"Antonoplis","year":"2019","journal-title":"ACS Chem Biol"},{"issue":"23","key":"10.1016\/j.nano.2023.102731_bb0100","doi-asserted-by":"crossref","first-page":"8823","DOI":"10.1002\/anie.202002727","article-title":"Vancomycin resistance is overcome by conjugation of polycationic peptides","volume":"59","author":"Umst\u00e4tter","year":"2020","journal-title":"Angew Chemie Int Ed"},{"issue":"7","key":"10.1016\/j.nano.2023.102731_bb0105","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.2215\/CJN.08140718","article-title":"Clinical pharmacology of antibiotics","volume":"14","author":"Eyler","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.nano.2023.102731_bb0110","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/1751143714564816","article-title":"Pharmacokinetic considerations and dosing strategies of antibiotics in the critically ill patient","volume":"16","author":"Shah","year":"2015","journal-title":"J Intensive Care Soc"},{"issue":"2","key":"10.1016\/j.nano.2023.102731_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/ph15020159","article-title":"Impact of linker modification and PEGylation of vancomycin conjugates on structure-activity relationships and pharmacokinetics","volume":"15","author":"Umst\u00e4tter","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"21","key":"10.1016\/j.nano.2023.102731_bb0120","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S1359-6446(05)03575-0","article-title":"PEGylation, successful approach to drug delivery","volume":"10","author":"Veronese","year":"2005","journal-title":"Drug Discov Today"},{"issue":"3","key":"10.1016\/j.nano.2023.102731_bb0125","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrd1033","article-title":"Effect of pegylation on pharmaceuticals","volume":"2","author":"Harris","year":"2003","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"10.1016\/j.nano.2023.102731_bb0130","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.3390\/molecules26072047","article-title":"Liposomes as antibiotic delivery systems: a promising nanotechnological strategy against antimicrobial resistance","volume":"26","author":"Ferreira","year":"2021","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.nano.2023.102731_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-022-01573-9","article-title":"Nanobiotics against antimicrobial resistance: harnessing the power of nanoscale materials and technologies","volume":"20","author":"Chakraborty","year":"2022","journal-title":"J Nanobiotechnology"},{"issue":"11","key":"10.1016\/j.nano.2023.102731_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/nano12111855","article-title":"Recent advances in antimicrobial nano-drug delivery systems","volume":"12","author":"Zong","year":"2022","journal-title":"Nanomaterials"},{"issue":"3","key":"10.1016\/j.nano.2023.102731_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics11030412","article-title":"Antimicrobial activity enhancers: towards smart delivery of antimicrobial agents","volume":"11","author":"Skwarczynski","year":"2022","journal-title":"Antibiotics"},{"issue":"10","key":"10.1016\/j.nano.2023.102731_bb0150","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1021\/acsinfecdis.9b00232","article-title":"Preserving the efficacy of glycopeptide antibiotics during nanoencapsulation in liposomes","volume":"5","author":"Gonzalez Gomez","year":"2019","journal-title":"ACS Infect Dis"},{"issue":"2","key":"10.1016\/j.nano.2023.102731_bb0155","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae - the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J Control Release"},{"issue":"3","key":"10.1016\/j.nano.2023.102731_bb0160","first-page":"297","article-title":"Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential","volume":"1","author":"Immordino","year":"2006","journal-title":"Int J Nanomedicine"},{"issue":"6","key":"10.1016\/j.nano.2023.102731_bb0165","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0163-7827(03)00033-X","article-title":"Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties","volume":"42","author":"Moghimi","year":"2003","journal-title":"Prog Lipid Res"},{"issue":"January","key":"10.1016\/j.nano.2023.102731_bb0170","doi-asserted-by":"crossref","first-page":"100384","DOI":"10.1016\/j.impact.2022.100384","article-title":"PEG-grafted liposomes for enhanced antibacterial and antibiotic activities: an in vivo study","volume":"25","author":"Alavi","year":"2022","journal-title":"NanoImpact"},{"issue":"4","key":"10.1016\/j.nano.2023.102731_bb0175","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3109\/08982100009031115","article-title":"Targeting of antibiotics in bacterial infections using pegylated long-circulating liposomes","volume":"10","author":"Bakker-Woudenberg","year":"2000","journal-title":"J Liposome Res"},{"issue":"8","key":"10.1016\/j.nano.2023.102731_bb0180","first-page":"2043","article-title":"Novel pyochelin-based PEGylated liposomes for enhanced delivery of antibiotics against resistant clinical isolates of Pseudomonas aeruginosa","volume":"46","author":"Pushparaj Selvadoss","year":"2018","journal-title":"Artif Cells, Nanomedicine Biotechnol"},{"issue":"10","key":"10.1016\/j.nano.2023.102731_bb0185","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1128\/AAC.00713-11","article-title":"PEGylated liposome encapsulation increases the lung tissue concentration of vancomycin","volume":"55","author":"Muppidi","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.nano.2023.102731_bb0190","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3390\/pharmaceutics14061153","article-title":"In vitro nephrotoxicity and permeation of vancomycin hydrochloride loaded liposomes","volume":"14","author":"Papp","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2023.102731_bb0195","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejpb.2016.03.031","article-title":"A liposomal formulation for the oral application of the investigational hepatitis B drug Myrcludex B","volume":"103","author":"Uhl","year":"2016","journal-title":"Eur J Pharm Biopharm"},{"issue":"August 2019","key":"10.1016\/j.nano.2023.102731_bb0200","doi-asserted-by":"crossref","first-page":"101538","DOI":"10.1016\/j.jddst.2020.101538","article-title":"Improving plasma stability and antitumor effect of gemcitabine via PEGylated liposome prepared by active drug loading","volume":"57","author":"Ding","year":"2020","journal-title":"J Drug Deliv Sci Technol"},{"issue":"11","key":"10.1016\/j.nano.2023.102731_bb0205","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/S0196-9781(02)00192-4","article-title":"Approaches to radioiodination of insect neuropeptides","volume":"23","author":"Crim","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.nano.2023.102731_bb0210","first-page":"72","article-title":"Blood volume in the rat","volume":"25","author":"Lee","year":"1985","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.nano.2023.102731_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics8040210","article-title":"Novel small-molecule antibacterials against gram-positive pathogens of Staphylococcus and Enterococcus species","volume":"8","author":"Seethaler","year":"2019","journal-title":"Antibiotics"},{"issue":"4","key":"10.1016\/j.nano.2023.102731_bb0220","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1021\/ja2084338","article-title":"Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake","volume":"134","author":"Walkey","year":"2012","journal-title":"J Am Chem Soc"},{"issue":"1","key":"10.1016\/j.nano.2023.102731_bb0230","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jconrel.2007.09.010","article-title":"Dual asymmetric centrifugation (DAC)-a new technique for liposome preparation","volume":"125","author":"Massing","year":"2008","journal-title":"J Control Release"},{"issue":"12","key":"10.1016\/j.nano.2023.102731_bb0235","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.2174\/1381612821666150115144003","article-title":"DSPE-PEG: a distinctive component in drug delivery system","volume":"21","author":"Che","year":"2015","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.nano.2023.102731_bb0240","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jconrel.2016.07.034","article-title":"Non-specific binding and steric hindrance thresholds for penetration of particulate drug carriers within tumor tissue","volume":"238","author":"Dancy","year":"2016","journal-title":"J Control Release"},{"issue":"2","key":"10.1016\/j.nano.2023.102731_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14020272","article-title":"PEGylated versus non-PEGylated pH-sensitive liposomes: new insights from a comparative antitumor activity study","volume":"14","author":"Nunes","year":"2022","journal-title":"Pharmaceutics"},{"issue":"24","key":"10.1016\/j.nano.2023.102731_bb0250","doi-asserted-by":"crossref","first-page":"10748","DOI":"10.1039\/D1NR02065J","article-title":"Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery","volume":"13","author":"Shi","year":"2021","journal-title":"Nanoscale"},{"issue":"4","key":"10.1016\/j.nano.2023.102731_bb0255","doi-asserted-by":"crossref","first-page":"6349","DOI":"10.1021\/acsnano.2c00423","article-title":"PEGylated liposomes accumulate in the areas relevant to skin toxicities via passive extravasation across \u2018leaky\u2019 endothelium","volume":"16","author":"Li","year":"2022","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.nano.2023.102731_bb0260","first-page":"11584","article-title":"Revealing dynamics of accumulation of systemically injected liposomes in the skin by intravital microscopy","volume":"11","author":"Griffin","year":"2018"},{"issue":"Supplement_1","key":"10.1016\/j.nano.2023.102731_bb0265","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1086\/491712","article-title":"The pharmacokinetic and pharmacodynamic properties of vancomycin","volume":"42","author":"Rybak","year":"2006","journal-title":"Clin Infect Dis"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963423000825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963423000825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:18:59Z","timestamp":1761549539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963423000825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":52,"alternative-id":["S1549963423000825"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2023.102731","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved pharmacokinetics and enhanced efficacy of the vancomycin derivative FU002 using a liposomal nanocarrier","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2023.102731","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102731"}}